abstract |
The present invention provides methods and compositions for extending the half-life of therapeutic agents. One or more half-life extending moieties can be attached to the therapeutic agent, thereby extending the half-life of the therapeutic agent. Modified therapeutic agents (mTAs) comprising one or more half-life-extending moieties attached to the therapeutic agent are useful for treating a disease or condition in a subject in need thereof. |